Skip to content

Chloroprocaine 2% versus prilocaine 1% for plexus anesthesia in outpatient procedures on forearm and hand

Chloroprocaine 2% versus prilocaine 1% for plexus anesthesia in outpatient procedures on forearm and hand

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00033417
Enrollment
60
Registered
2024-01-22
Start date
2024-06-28
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pathologies that require surgery on the forearm or hand under plexus anesthesia

Interventions

Group 1: Sonography-guided axillary plexus anesthesia with 30-40ml prilocaine 1% Group 2: Sonography-guided axillary plexus anesthesia with 30-40ml chloroprocaine 2%

Sponsors

BG Klinikum Unfallkrankenhaus Berlin gGmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients (male/female, outpatient) scheduled for axillary plexus anesthesia - Age: 18 years and older - ASA I-III

Exclusion criteria

Exclusion criteria: - General contraindications to plexus anesthesia - Pregnancy - Allergy to any of the medications provided for in the study protocol

Design outcomes

Primary

MeasureTime frame
Time until the motor and sensory block resolves is a key prerequisite for the ability to be discharged

Secondary

MeasureTime frame
• Surgery possible • Time of first onset of pain (NRS) • Maximum pain postoperatively (NRS) • Painkiller requirement (AWR) • Recording of occurring complications • Time of ability to be discharged (PADSS >= 9 points, plexus anesthesia declining) • Questionnaire Quality of recovery (QoR-9) • Follow-up interview after 7 days: • Pain scores of the 6 postoperative days (maximum, average) • Analgesics taken as planned? • Additional analgesics were necessary?

Countries

Germany

Contacts

Public ContactVolker Gebhardt

BG Klinikum Unfallkrankenhaus Berlin gGmbH

volker.gebhardt@ukb.de030 5681 3102

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026